agilon health, inc. reported $5.92B of revenue over the trailing twelve months, +0.32% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.92B (to Q2 2026). Net income: −$232M, trailing twelve months to Q2 2026. Free cash flow: −$85M, trailing twelve months to Q2 2026. Operating margin: −5.1%, trailing twelve months to Q2 2026.

AGLagilon health, inc.

Healthcare

$82.66+185% 1Y

$82.66

$7.9152 weeks$129.35

AGL as reported

agilon health, inc. reported $5.92B of revenue over the trailing twelve months, +0.32% on the year before. 9 reported series are charted on this page, each one as filed.

$5.92B

Revenue, trailing twelve months · to Q2 2026 · +0.32% against the twelve months before

Net income: −$232M
Net income · −26% year on year · trailing twelve months to Q2 2026
Free cash flow: −$85M
Free cash flow · +18% year on year · trailing twelve months to Q2 2026
Operating margin: −5.1%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AGL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.92B	+0.32%	Q2 2026
Net income	−$232M	−26%	Q2 2026
EPS	−$15.41	−24%	Q2 2026
Operating margin	−5.1%	n/a	Q2 2026
Net margin	−3.8%	n/a	Q2 2026
ROE	−177%	n/a	Q2 2026
ROA	−22%	n/a	Q2 2026
ROIC	558%	n/a	Q2 2026
Free cash flow	−$85M	+18%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.